No black box warning on record for Argatroban

As of the latest FDA labeling reviewed, Argatroban (ARGATROBAN) does not carry a black box warning. Standard warnings and precautions still apply — see the full Argatroban medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Hemorrhage can occur. Unexplained fall in hematocrit or blood pressure may indicate hemorrhage. ( 5.1 ) Hepatic impairment: Adjust starting dose and titrate carefully in patients with HIT who have moderate or severe hepatic impairment. Avoid use in PCI in patients with clinically significant hepatic impairment. ( 5.2 ) 5.1 Risk of Hemorrhage Hemorrhage can occur at any

No black box warning on record for Argatroban

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Hemorrhage can occur. Unexplained fall in hematocrit or blood pressure may indicate hemorrhage. ( 5.1 ) Hepatic impairment: Adjust starting dose and titrate carefully in patients with HIT who have moderate or severe hepatic impairment. Avoid use in PCI in patients with clinically significant hepatic impairment. ( 5.2 ) 5.1 Risk of Hemorrhage Hemorrhage can occur at any

Argatroban Black Box Warning

No black box warning on record for Argatroban

Other warnings & precautions

Argatroban Black Box Warning

No black box warning on record for Argatroban

Other warnings & precautions